BOSTON–(BUSINESS WIRE)–NWN Carousel, the leading integrated Cloud Communications Service Provider, today announced it has received…
SANTA CLARA, Calif.–(BUSINESS WIRE)–#AI—CLARA Analytics (“CLARA”), the leading provider of artificial intelligence (AI) technology in…
Expert Insights names Egress Protect the ‘top email encryption solution for Office 365’. London –…
Migrating to a secure, compliant cloud infrastructure through ClearDATA’s managed services, Apricus Health enhanced patient…
Foundation will promote a diverse and inclusive workforce, advance free and open solutions for underserved…
LEXINGTON, Mass., April 05, 2022 (GLOBE NEWSWIRE) — Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company…
ISELIN, N.J., April 05, 2022 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical…
SAN CARLOS, Calif., April 05, 2022 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage…
SOUTH SAN FRANCISCO, Calif., April 05, 2022 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX),…
LAS VEGAS, April 05, 2022 (GLOBE NEWSWIRE) — CLS Holdings USA, Inc. (OTCQB:CLSH) (CSE:CLSH), the…
– Total Product Revenues Expected in the Range of $450.0 million to $465.0 million –…
XMT-1660 demonstrates robust activity in preclinical models of breast cancer XMT-2056 demonstrates robust activity as…
–Seasoned physician, scientist and life science executive brings expertise in clinical research and development across…
LONDON, April 05, 2022 (GLOBE NEWSWIRE) — Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical…
A Potential Multi-Billion Dollar Global Market Opportunity for Cancer Treatments MONTREAL, April 05, 2022 (GLOBE…
CAMBRIDGE, Mass., April 05, 2022 (GLOBE NEWSWIRE) — Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan”) a…
BELTSVILLE, Md., April 05, 2022 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical…
CARMEL, Ind., April 05, 2022 (GLOBE NEWSWIRE) — MBX Biosciences, Inc., a clinical stage biopharmaceutical…
Dr. Mellion brings deep experience in neuromuscular disease research and treatment as a biopharma executive,…
WINNIPEG, Manitoba, April 05, 2022 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the…